Skip to main content

Table 1 Patient characteristics

From: Better survival in right-sided versus left-sided stage I - III colon cancer patients

 

Patient characteristics

  

Total

Right-sided carcinoma

Left-sided carcinoma

Pa

N = 91,416

N = 51,937

N = 39,479

Tumor stage

Stage I

25,482 (27.9 %)

13,864 (26.7 %)

11,618 (29.4 %)

<0.001

(AJCC 6th ed.)

Stage II

33,323 (36.5 %)

19,965 (38.4 %)

13,358 (33.8 %)

 
 

Stage III

32,611 (35.7 %)

18,108 (34.9 %)

14,503 (36.7 %)

 

T-stage

T1

14,110 (15.4 %)

6415 (12.4 %)

7695 (19.5 %)

<0.001

 

T2

15,873 (17.4 %)

9580 (18.4 %)

6293 (15.9 %)

 
 

T3

51,416 (56.2 %)

29,980 (57.7 %)

21,436 (54.3 %)

 
 

T4

10,017 (11.0 %)

5962 (11.5 %)

4055 (10.3 %)

 

Number of positive

0

58,805 (64.3 %)

33,829 (65.1 %)

24,976 (63.3 %)

<0.001

regional lymph nodes

1

10,557 (11.5 %)

5627 (10.8 %)

4930 (12.5 %)

 
 

2–3

10,531 (11.5 %)

5672 (10.9 %)

4859 (12.3 %)

 
 

4–6

6560 (7.2 %)

3692 (7.1 %)

2868 (7.3 %)

 
 

7+

4963 (5.4 %)

3117 (6.0 %)

1846 (4.7 %)

 

Number of retrieved

<12 lymph nodes

24,256 (26.5 %)

10,243 (19.7 %)

14,013 (35.5 %)

<0.001

regional lymph nodes

12–16 lymph nodes

26,123 (28.6 %)

14,917 (28.7 %)

11,206 (28.4 %)

 
 

17+ lymph nodes

41,037 (44.9 %)

26,777 (51.6 %)

14,260 (36.1 %)

 

Grading

G1

8568 (9.4 %)

4721 (9.1 %)

3847 (9.7 %)

<0.001

 

G2

64,221 (70.3 %)

34,812 (67.0 %)

29,409 (74.5 %)

 
 

G3

14,228 (15.6 %)

9886 (19.0 %)

4342 (11.0 %)

 
 

G4

1490 (1.6 %)

1099 (2.1 %)

391 (1.0 %)

 
 

Unknown

2909 (3.2 %)

1419 (2.7 %)

1490 (3.8 %)

 

Histology

Adenocarcinoma

64,760 (70.8 %)

35,637 (68.6 %)

29,123 (73.8 %)

<0.001

 

Adeno-Ca in adenomatous polyp

6791 (7.4 %)

2885 (5.6 %)

3906 (9.9 %)

 
 

Adeno-Ca in villous adenoma

2646 (2.9 %)

1721 (3.3 %)

925 (2.3 %)

 
 

Adeno-Ca in tubulovillous adenoma

8142 (8.9 %)

4897 (9.4 %)

3245 (8.2 %)

 
 

Mucinous carcinoma

9077 (9.9 %)

6797 (13.1 %)

2280 (5.8 %)

 

CEA

C0-stage

32,999 (36.1 %)

18,679 (36.0 %)

14,320 (36.3 %)

0.185

 

C1-stage

17,232 (18.9 %)

9896 (19.1 %)

7336 (18.6 %)

 
 

Unknown/Borderline

41,185 (45.1 %)

23,362 (45.0 %)

17,823 (45.1 %)

 

Operation

Segmental resection

36,201 (39.6 %)

7750 (14.9 %)

28,451 (72.1 %)

<0.001

 

Hemi/subtotal colectomy

54,241 (59.3 %)

43,777 (84.3 %)

10,464 (26.5 %)

 
 

Other

974 (1.1 %)

410 (0.8 %)

564 (1.4 %)

 

Year

2004 to 2006

31,514 (34.5 %)

17,703 (34.1 %)

13,811 (35.0 %)

0.005

 

2007 to 2009

31,314 (34.3 %)

17,798 (34.3 %)

13,516 (34.2 %)

 
 

2010 to 2012

28,588 (31.3 %)

16,436 (31.6 %)

12,152 (30.8 %)

 

Age

Up to 49 years

8015 (8.8 %)

3175 (6.1 %)

4840 (12.3 %)

<0.001

 

50 to 64 years

26,347 (28.8 %)

12,344 (23.8 %)

14,003 (35.5 %)

 
 

65 to 79 years

35,693 (39.0 %)

21,435 (41.3 %)

14,258 (36.1 %)

 
 

80+ years

21,361 (23.4 %)

14,983 (28.8 %)

6378 (16.2 %)

 

Gender

Male

43,981 (48.1 %)

23,053 (44.4 %)

20,928 (53.0 %)

<0.001

 

Female

47,435 (51.9 %)

28,884 (55.6 %)

18,551 (47.0 %)

 

Ethnicity

Caucasian

72,937 (79.8 %)

42,296 (81.4 %)

30,641 (77.6 %)

<0.001

 

African-American

10,572 (11.6 %)

6286 (12.1 %)

4286 (10.9 %)

 
 

Other/Unknown

7907 (8.6 %)

3355 (6.5 %)

4552 (11.5 %)

 

Marital status

Married

49,901 (54.6 %)

27,219 (52.4 %)

22,682 (57.5 %)

<0.001

 

Single

11,581 (12.7 %)

6120 (11.8 %)

5461 (13.8 %)

 
 

Widowed

17,770 (19.4 %)

11,835 (22.8 %)

5935 (15.0 %)

 
 

Other/Unknown

12,164 (13.3 %)

6763 (13.0 %)

5401 (13.7 %)

 
  1. All data shown as n (%)
  2. AJCC, American Joint Committee on Cancer, T-stage tumor stage, CEA Carcinoembryonic antigen
  3. aChi-Square test